Mohit Sodhi
Vancouver, BC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Incorrect Conclusions From Misinterpreting Point Estimates and CIs.
Journal: JAMA ophthalmology
Published: July 24, 2025
Use of medroxyprogesterone acetate and risk of meningiomas: a comparative safety study.
Journal: Expert opinion on drug safety
Published: June 30, 2025
GLP-1 RAs and Nonarteritic Anterior Ischemic Optic Neuropathy-Making Sense of the Data.
Journal: JAMA ophthalmology
Published: January 30, 2025
Gastrointestinal Safety Assessment of GLP-1 Receptor Agonists in the US: A Real-World Adverse Events Analysis from the FAERS Database.
Journal: Diagnostics (Basel, Switzerland)
Published: November 14, 2024
GLP-1 Receptor Agonists and Gastrointestinal Adverse Events-Reply.
Journal: JAMA
Published: March 12, 2024
Increased risk of pigmentary degeneration of the iris and pigmentary glaucoma with fluoroquinolone antibiotics.
Journal: Eye (London, England)
Published: December 11, 2023
Reply: Misidentified Dopamine Agonists Undermine Investigation Into Aripiprazole Link With Impulse Control Disorders.
Journal: Journal of clinical psychopharmacology
Published: February 23, 2023
Risk of Ocular Adverse Events With Taxane-Based Chemotherapy.
Journal: JAMA ophthalmology
Published: August 11, 2022
In Defense of Phosphodiesterase 5 Inhibitors-Reply.
Journal: JAMA ophthalmology
Published: July 21, 2022
Association of Topical Prostaglandin Analogue Use With Risk of Spontaneous Abortion.
Journal: JAMA ophthalmology
Published: April 28, 2022
Risk of Ocular Adverse Events Associated With Use of Phosphodiesterase 5 Inhibitors in Men in the US.
Journal: JAMA ophthalmology
Published: April 07, 2022
Last Updated: 09/26/2026